Acute kidney injury linked to in-hospital mortality, even after adjustment for confounding variables.
AKI occurs frequently among patients admitted to hospitals with COVID-19, and it independently predicts an increased risk of in-hospital mortality.
Recent advances in cancer management may present challenges for nephrologists.
Patients who experienced acute kidney injury during hospitalization for COVID-19, compared with those who did not, had greater proteinuria and ɑ1-microglobulin excretion at admission, a study found.
Patients hospitalized with COVID-19 who have preexisting kidney conditions are more susceptible to renal complications, a new systematic review and meta-analysis suggest.
In a randomized trial, investigators observed no significant survival difference between acute kidney injury patients who did and did not initiate renal replacement therapy within 12 hours.
Upon starting methotrexate treatment, LDH and albumin levels may be signals for AKIs in patients with hematologic malignancies.
In critically ill patients with acute kidney injury, more intensive renal replacement therapy may lead to a greater risk of failure to extubate from mechanical ventilation.
Kidney failure due to acute kidney injury is associated with a significantly higher death risk in the first 6 months following dialysis initiation than kidney failure resulting from diabetes, a study found.
In a propensity score matched analysis, patients with a history of acute kidney injury (AKI) had a significant 43% lower risk of kidney stones than those who never experienced AKI.